SecBot SecBot
SECBOTREPLAY Home › Report › KALV

KALV · Two C-suite executives at KalVista Pharmaceuticals, the CFO and Chief…

KalVista Pharmaceuticals, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Two C-suite executives at KalVista Pharmaceuticals, the CFO and Chief Commercial Officer, sold shares worth $89,385 in the past week, following recent option exercises. The sales are part of a planned disposition after exercising options, not open-market selling, and no new insider buying was detected.

  • CFO Brian Piekos sold 1,767 shares for $27,507 at $15.57/share on 2026-02-23
  • CCO Nicole Sweeny sold 3,975 shares for $61,878 at $15.57/share on 2026-02-23
  • Both executives exercised stock options on 2026-02-21 and 2026-02-22 (totaling 11,250 shares) at $0 price, indicating prior grant exercise
  • Total insider sell activity in cluster: $89,385

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access